Biotech stock #6: Illumina (ILMN)


biotech stocks illuminaDo you think we're going to see more or less genomics research in coming years? End of discussion.

Illumina (NASDAQ: ILMN) is the leading provider of equipment for genomics researchers and its lead is growing. Buy and hold may be almost dead, but it certainly applies to ILMN. The stock has been trashed along with the market, but it's simply the best at what it does - and getting better.

Your best strategy for life-changing profits?

This is a stock to buy for the long term to use as a base for selling calls. Or, even better, you can write some credit spreads, as the calls have terrific premiums.

Don't miss the complete list of biotech stocks to buy now.

And for more ways to profit, check out:

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+5.7512,883.95
NASDAQ+11.782,915.86
S&P 500+2.911,349.96

Last updated: February 09, 2012: 08:21 AM

Hot Stocks

General Electric

19.24+0.06(+0.31)

Alcoa

10.670.00(0.00)

Apple Inc

476.68+7.85(+1.67)

Google Inc 'A'

609.85+3.08(+0.51)

Bank of America

8.13+0.28(+3.57)

Wal-Mart Stores

61.62-0.07(-0.11)

Exxon Mobil Corp

85.32-0.55(-0.64)

Ford

12.84-0.04(-0.31)

Citigroup

34.23+1.16(+3.51)

IBM

192.95+0.35(+0.18)

Yahoo

15.78-0.05(-0.32)

Starbucks

48.72+0.31(+0.64)

Microsoft

30.66+0.31(+1.02)

Home Depot

45.17-0.29(-0.64)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328793661932 ms.